Barely Significant
← all excerpts

Advances in Clinical Cardiology 2022: A Summary of Key Clinical Trials.

Adv Ther · 2023 · PMC10100625 · PMID 37052800

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

showed a trendP = 0.07so close (0.05 < p ≤ 0.1)
At a median fgollow up of 2.7 years, ferric derisomaltose showed a trend to reduction in the primary composite endpoint of HF hospitalisation and CV death (336 vs. 411 events; RR 0.82, 95% CI 0.66–1.02; P = 0.07) and a significant reduction in HF hospitalisations.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.